doi: 10.2214/AJR.04.1932.
Imaging features of hepatocellular carcinoma after transcatheter arterial chemoembolization and radiofrequency ablation
Affiliations
- PMID: 16985104
- DOI: 10.2214/AJR.04.1932
Item in Clipboard
Imaging features of hepatocellular carcinoma after transcatheter arterial chemoembolization and radiofrequency ablation
AJR Am J Roentgenol.
2006 Oct.
Abstract
Objective: The purpose of this pictorial essay is to show the imaging features of hepatocellular carcinoma (HCC) after transcatheter arterial chemoembolization (TACE) and radiofrequency thermal ablation on CT, MRI, and contrast-enhanced sonography and to describe the advantages and limitations of each imaging technique in evaluating the therapeutic effect on HCC.
Conclusion: CT is the standard imaging technique for monitoring the effectiveness of TACE and radiofrequency ablation. Contrast-enhanced sonography and MRI can complement CT in evaluating the therapeutic response.
Similar articles
-
[Hepatocellular carcinoma: Role of imaging diagnostics in detection, intervention and follow-up].Rofo. 2002 Nov;174(11):1358-68. doi: 10.1055/s-2002-35349. Rofo. 2002. PMID: 12424661 Review. German.
-
Carbon dioxide-enhanced sonographically guided radiofrequency ablation plus transcatheter arterial chemoembolization for hepatocellular carcinoma.J Vasc Interv Radiol. 2006 Apr;17(4):723-6. doi: 10.1097/01.RVI.0000197369.10849.29. J Vasc Interv Radiol. 2006. PMID: 16614157
-
Image fusion with volume navigation of contrast enhanced ultrasound (CEUS) with computed tomography (CT) or magnetic resonance imaging (MRI) for post-interventional follow-up after transcatheter arterial chemoembolization (TACE) of hepatocellular carcinomas (HCC): Preliminary results.Clin Hemorheol Microcirc. 2010;46(2-3):101-15. doi: 10.3233/CH-2010-1337. Clin Hemorheol Microcirc. 2010. PMID: 21135486
-
[Clinical study of transcatheter arterial chemoembolization plus radiofrequency ablation in hepatocellular carcinoma by magnetic resonance imaging and functional diffusion-weighted imaging].Zhonghua Yi Xue Za Zhi. 2010 Nov 9;90(41):2922-6. Zhonghua Yi Xue Za Zhi. 2010. PMID: 21211398 Chinese.
-
Therapeutic response assessment of transcatheter arterial chemoembolization for hepatocellular carcinoma: ultrasonography, CT and MR imaging.Oncology. 2013;84 Suppl 1:58-63. doi: 10.1159/000345891. Epub 2013 Feb 20. Oncology. 2013. PMID: 23428860 Review.
Cited by
-
Predictive value of immunogenic cell death biomarkers HMGB1, sRAGE, and DNase in liver cancer patients receiving transarterial chemoembolization therapy.Tumour Biol. 2012 Dec;33(6):2401-9. doi: 10.1007/s13277-012-0504-2. Epub 2012 Sep 11. Tumour Biol. 2012. PMID: 22965881
-
Relevance of circulating nucleosomes and oncological biomarkers for predicting response to transarterial chemoembolization therapy in liver cancer patients.BMC Cancer. 2011 May 26;11:202. doi: 10.1186/1471-2407-11-202. BMC Cancer. 2011. PMID: 21615953 Free PMC article.
-
Hepatocellular carcinoma treated with transarterial chemoembolization: dynamic perfusion-CT in the assessment of residual tumor.World J Gastroenterol. 2010 Dec 21;16(47):5993-6000. doi: 10.3748/wjg.v16.i47.5993. World J Gastroenterol. 2010. PMID: 21157976 Free PMC article.
-
MRI Assessment of Hepatocellular Carcinoma after Local-Regional Therapy: A Comprehensive Review.Radiol Imaging Cancer. 2020 Jan 31;2(1):e190024. doi: 10.1148/rycan.2020190024. eCollection 2020 Jan. Radiol Imaging Cancer. 2020. PMID: 33778692 Free PMC article. Review.
-
Accuracy of Contrast-Enhanced Ultrasound for Hepatocellular Carcinoma Post-Transcatheter Arterial Embolization.J Clin Med. 2024 Dec 18;13(24):7720. doi: 10.3390/jcm13247720. J Clin Med. 2024. PMID: 39768642 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
